Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Shengping Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8309-4078; OpenAlex author ID A5100732817. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 3 papers · 2026: 1 paper

Papers 7

  1. Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study. Co-author DOI 10.3389/fimmu.2026.1841783↗
  2. Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propens… Co-author DOI 10.3389/fimmu.2025.1620988↗
  3. Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreati… Last author DOI 10.3389/fimmu.2025.1688440↗
  4. Treatment options in patients with pancreatic cancer: A 10-year multicenter epidemiological investigation in China. Co-author DOI 10.4251/wjgo.v17.i8.106447↗
  5. Triglyceride-glucose index and glycemic dynamics in pancreatic ductal adenocarcinoma: implications for disease progression and prognosis. Last author DOI 10.1186/s12967-024-05524-w↗
  6. Treatment of locally advanced pancreatic cancer with irreversible electroporation and intraoperative radiotherapy. Last author DOI 10.21037/hbsn-24-526↗
  7. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.25110↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingmin Jiang · 4 shared papers, 2024–2026 · strength 1.12
  2. Chaobin He · 2 shared papers, 2025–2026 · strength 0.60
  3. Pu Xi · 2 shared papers, 2025–2026 · strength 0.60
  4. Zehui Yao · 2 shared papers, 2025 · strength 0.57
  5. Qiang Tao · 1 shared paper, 2026 · strength 0.32
  6. Dailei Qin · 1 shared paper, 2025 · strength 0.28
  7. Yunda Song · 1 shared paper, 2024 · strength 0.28
  8. Wanyi Sun · 1 shared paper, 2025 · strength 0.25
  9. Renyi Qin · 1 shared paper, 2025 · strength 0.25
  10. Chengfeng Wang · 1 shared paper, 2025 · strength 0.25
  11. Rufu Chen · 1 shared paper, 2025 · strength 0.25
  12. Jin‐Hu Fan · 1 shared paper, 2025 · strength 0.25
  13. Xin Huang · 1 shared paper, 2024 · strength 0.24
  14. Po‐Chih Yang · 1 shared paper, 2018 · strength 0.09
  15. Uei Pua · 1 shared paper, 2018 · strength 0.09
  16. Yudong Qiu · 1 shared paper, 2018 · strength 0.09
  17. Po‐Chin Liang · 1 shared paper, 2018 · strength 0.09
  18. Kai‐Wen Huang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.